Institutional investors purchased a net $2.4 million shares of DEPO during the quarter ended June 2016 and now own 107.57% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NAYA CAPITAL MANAGEMENT UK LTD. Bought 1.6 Million shares of Depomed Inc
SCOGGIN MANAGEMENT LP Bought 1.5 Million shares of Depomed Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 558.9 Thousand shares of Depomed Inc